Explore the section for more details about the clinical studies conducted by Dompé
A randomized, double-blind, placebo-controlled phase 2 study of pacilitaxel as front-line therapy of Metastatic Triple-Negative Breast Cancer
Find a centre
Search in the map your nearest centre
Copyright 2017 © Dompé farmaceutici S.p.A. All rights reserved.
Dompè does not assume any responsibility for the contents